NEO
$9.58
Revenue | $172Mn |
Net Profits | $-15.32Mn |
Net Profit Margins | -8.91% |
Neogenomics, Inc.’s revenue jumped 10.57% since last year same period to $172Mn in the Q4 2024. On a quarterly growth basis, Neogenomics, Inc. has generated 2.49% jump in its revenue since last 3-months.
Neogenomics, Inc.’s net profit fell -6.97% since last year same period to $-15.32Mn in the Q4 2024. On a quarterly growth basis, Neogenomics, Inc. has generated 13.42% jump in its net profits since last 3-months.
Neogenomics, Inc.’s net profit margin jumped 3.26% since last year same period to -8.91% in the Q4 2024. On a quarterly growth basis, Neogenomics, Inc. has generated 15.52% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.01 |
EPS Estimate Current Year | -0.01 |
Neogenomics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.01 - a -117.48% fall from last quarter’s estimates.
Neogenomics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.01.
Earning Per Share (EPS) | 0.04 |
Neogenomics, Inc.’s earning per share (EPS) jumped 33.33% since last year same period to 0.04 in the Q4 2024. This indicates that the Neogenomics, Inc. has generated 33.33% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-04-30 | -0.05 | -0.02 | 60% |
2024-07-30 | -0 | 0.03 | 1404.35% |
2024-11-05 | 0.01 | -0.14 | -1494% |
2025-02-18 | 0.03 | 0.04 | 39.86% |